$7 Billion is the total value of Orbimed Advisors's 136 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 51.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $465,092,000 | +29.8% | 3,343,100 | -10.1% | 6.64% | -2.3% |
| THOR | SYNTHORX INC | $371,560,000 | +329.6% | 5,316,355 | 0.0% | 5.30% | +223.3% | |
| TCDA | Sell | TRICIDA INC | $362,843,000 | +5.8% | 9,614,280 | -13.5% | 5.18% | -20.4% |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $285,069,000 | +77.5% | 7,406,307 | 0.0% | 4.07% | +33.6% | |
| PRVL | PREVAIL THERAPEUTICS INC | $218,810,000 | +28.9% | 13,822,463 | 0.0% | 3.12% | -3.0% | |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $211,394,000 | -1.4% | 4,674,800 | -11.3% | 3.02% | -25.8% |
| ALEC | Sell | ALECTOR INC | $189,322,000 | +4.8% | 10,987,944 | -12.3% | 2.70% | -21.2% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $179,809,000 | +10.4% | 1,662,585 | -0.0% | 2.57% | -17.0% |
| MRK | MERCK & CO INC | $177,725,000 | +8.0% | 1,954,100 | 0.0% | 2.54% | -18.7% | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $172,750,000 | +314.3% | 1,340,600 | +150.5% | 2.47% | +211.8% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $171,460,000 | +19.6% | 783,100 | -7.5% | 2.45% | -10.0% |
| TPTX | TURNING POINT THERAPEUTICS I | $171,006,000 | +65.7% | 2,745,327 | 0.0% | 2.44% | +24.6% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $153,578,000 | +52.1% | 5,548,326 | 0.0% | 2.19% | +14.5% | |
| NXTC | NEXTCURE INC | $152,711,000 | +82.6% | 2,711,013 | 0.0% | 2.18% | +37.4% | |
| HUM | Buy | HUMANA INC | $143,639,000 | +209.0% | 391,900 | +115.6% | 2.05% | +132.5% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $109,123,000 | – | 1,700,000 | +100.0% | 1.56% | – |
| EHTH | Sell | EHEALTH INC | $106,833,000 | +43.1% | 1,111,914 | -0.5% | 1.52% | +7.7% |
| ETNB | New | 89BIO INC | $105,277,000 | – | 4,004,442 | +100.0% | 1.50% | – |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $101,458,000 | -9.1% | 434,900 | -14.4% | 1.45% | -31.6% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $100,607,000 | -29.1% | 935,970 | -40.6% | 1.44% | -46.7% |
| CI | Buy | CIGNA CORP NEW | $100,139,000 | +126.2% | 489,700 | +67.9% | 1.43% | +70.2% |
| INSP | Sell | INSPIRE MED SYS INC | $99,961,000 | +11.4% | 1,347,000 | -8.4% | 1.43% | -16.2% |
| ARQL | Buy | ARQULE INC | $99,800,000 | +276.1% | 5,000,000 | +35.1% | 1.42% | +182.7% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $99,195,000 | -10.6% | 167,800 | -18.4% | 1.42% | -32.8% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $98,851,000 | +56.7% | 766,049 | -8.5% | 1.41% | +17.9% |
| DHR | New | DANAHER CORPORATION | $98,058,000 | – | 638,900 | +100.0% | 1.40% | – |
| BHC | Sell | BAUSCH HEALTH COS INC | $95,238,000 | +31.6% | 3,183,100 | -3.9% | 1.36% | -0.9% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $94,242,000 | +12.8% | 1,514,171 | -38.5% | 1.34% | -15.1% |
| GKOS | New | GLAUKOS CORP | $84,300,000 | – | 1,547,646 | +100.0% | 1.20% | – |
| PTCT | Sell | PTC THERAPEUTICS INC | $83,053,000 | +25.4% | 1,729,200 | -11.7% | 1.19% | -5.6% |
| NTRA | Sell | NATERA INC | $82,224,000 | -16.4% | 2,440,613 | -18.6% | 1.17% | -37.1% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $78,588,000 | +24.2% | 209,300 | -8.2% | 1.12% | -6.6% |
| ARVN | Sell | ARVINAS INC | $78,022,000 | +72.8% | 1,898,800 | -9.4% | 1.11% | +30.0% |
| QURE | Buy | UNIQURE NV | $77,519,000 | +134.6% | 1,081,765 | +28.8% | 1.11% | +76.6% |
| TMO | Sell | THERMO FISHER SCIENTIFIC INC | $71,634,000 | -30.1% | 220,500 | -37.3% | 1.02% | -47.4% |
| MGTX | Buy | MEIRAGTX HOLDINGS PLC | $69,129,000 | +29.4% | 3,453,020 | +3.1% | 0.99% | -2.7% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $68,038,000 | +73.6% | 1,141,390 | +71.8% | 0.97% | +30.5% |
| EXEL | Sell | EXELIXIS INC | $66,140,000 | -4.4% | 3,753,700 | -4.1% | 0.94% | -28.1% |
| ABT | Sell | ABBOTT LABS | $62,114,000 | -9.7% | 715,100 | -13.0% | 0.89% | -32.1% |
| HZNP | New | HORIZON THERAPEUTICS PUB LTD | $57,279,000 | – | 1,582,300 | +100.0% | 0.82% | – |
| KRYS | Buy | KRYSTAL BIOTECH INC | $55,092,000 | +163.6% | 994,808 | +65.3% | 0.79% | +98.2% |
| BLU | BELLUS HEALTH INC NEW | $53,137,000 | +17.7% | 7,025,832 | 0.0% | 0.76% | -11.3% | |
| DXCM | Sell | DEXCOM INC | $51,382,000 | -10.3% | 234,900 | -38.8% | 0.73% | -32.5% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $51,166,000 | +66.8% | 2,039,282 | 0.0% | 0.73% | +25.4% | |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $50,022,000 | +128.7% | 4,342,190 | +8.2% | 0.71% | +72.0% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $47,519,000 | +152.0% | 2,345,447 | -33.6% | 0.68% | +89.4% |
| CRSP | Buy | CRISPR THERAPEUTICS AGnamen akt | $46,676,000 | +120.5% | 766,378 | +48.4% | 0.67% | +65.7% |
| LOGC | LOGICBIO THERAPEUTICS INC | $46,561,000 | -33.4% | 6,466,783 | 0.0% | 0.66% | -49.8% | |
| PRTA | Sell | PROTHENA CORP PLC | $45,942,000 | +93.9% | 2,902,239 | -4.0% | 0.66% | +45.8% |
| ATNX | Sell | ATHENEX INC | $42,332,000 | +5.2% | 2,772,221 | -16.2% | 0.60% | -20.9% |
| ARGX | Sell | ARGENX SEsponsored adr | $41,141,000 | +16.3% | 256,300 | -17.4% | 0.59% | -12.5% |
| TELA | New | TELA BIO INC | $39,207,000 | – | 3,027,542 | +100.0% | 0.56% | – |
| CRVS | CORVUS PHARMACEUTICALS INC | $36,816,000 | +80.7% | 6,767,584 | 0.0% | 0.53% | +35.9% | |
| HARP | HARPOON THERAPEUTICS INC | $36,182,000 | +8.3% | 2,446,409 | 0.0% | 0.52% | -18.5% | |
| ANTM | Sell | ANTHEM INC | $32,196,000 | -47.3% | 106,600 | -58.1% | 0.46% | -60.3% |
| AMGN | AMGEN INC | $29,435,000 | +24.6% | 122,100 | 0.0% | 0.42% | -6.2% | |
| HCA | New | HCA HEALTHCARE INC | $28,084,000 | – | 190,000 | +100.0% | 0.40% | – |
| IQV | IQVIA HLDGS INC | $27,039,000 | +3.4% | 175,000 | 0.0% | 0.39% | -22.2% | |
| APLT | New | APPLIED THERAPEUTICS INC | $26,930,000 | – | 987,186 | +100.0% | 0.38% | – |
| ZBH | New | ZIMMER BIOMET HLDGS INC | $26,748,000 | – | 178,700 | +100.0% | 0.38% | – |
| VRCA | VERRICA PHARMACEUTICALS INC | $23,513,000 | +7.7% | 1,479,733 | 0.0% | 0.34% | -18.8% | |
| PHGE | New | BIOMX INC | $22,406,000 | – | 2,313,489 | +100.0% | 0.32% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $21,893,000 | -0.6% | 2,865,524 | 0.0% | 0.31% | -25.1% | |
| ZLAB | ZAI LAB LTDadr | $21,377,000 | +28.6% | 514,000 | 0.0% | 0.30% | -3.5% | |
| GILD | GILEAD SCIENCES INC | $21,190,000 | +2.5% | 326,100 | 0.0% | 0.30% | -22.7% | |
| ALC | ALCON INC | $19,925,000 | -2.8% | 351,380 | 0.0% | 0.28% | -27.0% | |
| SCPH | SCPHARMACEUTICALS INC | $19,300,000 | -3.6% | 3,409,865 | 0.0% | 0.28% | -27.4% | |
| BIIB | Buy | BIOGEN INC | $19,139,000 | +127.1% | 64,500 | +78.2% | 0.27% | +70.6% |
| NVO | NOVO-NORDISK A Sadr | $19,100,000 | +12.0% | 330,000 | 0.0% | 0.27% | -15.7% | |
| AVTR | New | AVANTOR INC | $18,382,000 | – | 1,012,800 | +100.0% | 0.26% | – |
| SVA | SINOVAC BIOTECH LTD | $17,151,000 | +3.3% | 2,839,500 | 0.0% | 0.24% | -22.2% | |
| XTNT | XTANT MED HLDGS INC | $14,731,000 | -43.7% | 9,207,012 | 0.0% | 0.21% | -57.7% | |
| ALPN | ALPINE IMMUNE SCIENCES INC | $14,096,000 | -3.0% | 3,670,955 | 0.0% | 0.20% | -27.2% | |
| KALA | KALA PHARMACEUTICALS INC | $12,723,000 | -3.0% | 3,447,840 | 0.0% | 0.18% | -26.9% | |
| AVRO | Buy | AVROBIO INC | $12,777,000 | +58.6% | 634,700 | +11.2% | 0.18% | +19.0% |
| XBI | New | SPDR SERIES TRUSTs&p biotech | $12,098,000 | – | 127,200 | +100.0% | 0.17% | – |
| MRSN | Buy | MERSANA THERAPEUTICS INC | $11,880,000 | +297.6% | 2,073,319 | +9.6% | 0.17% | +198.2% |
| KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $11,922,000 | +16.3% | 621,900 | -41.7% | 0.17% | -12.8% |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $11,625,000 | -2.3% | 1,086,493 | +16.0% | 0.17% | -26.5% |
| XLV | New | SELECT SECTOR SPDR TRsbi healthcare | $11,531,000 | – | 113,200 | +100.0% | 0.16% | – |
| NLTX | New | NEOLEUKIN THERAPEUTICS INC | $11,088,000 | – | 900,000 | +100.0% | 0.16% | – |
| XBI | New | SPDR SERIES TRUSTcall | $10,462,000 | – | 110,000 | +100.0% | 0.15% | – |
| OBSV | OBSEVA SA | $9,953,000 | -54.1% | 2,605,531 | 0.0% | 0.14% | -65.5% | |
| FOMX | Sell | FOAMIX PHARMACEUTICALS LTD | $8,585,000 | -41.0% | 2,577,982 | -46.2% | 0.12% | -55.4% |
| ISEE | New | IVERIC BIO INC | $8,580,000 | – | 1,000,000 | +100.0% | 0.12% | – |
| XENE | XENON PHARMACEUTICALS INC | $8,322,000 | +45.5% | 634,812 | 0.0% | 0.12% | +9.2% | |
| EPIX | ESSA PHARMA INC | $8,095,000 | +63.2% | 1,471,853 | 0.0% | 0.12% | +23.4% | |
| CTIC | CTI BIOPHARMA CORP | $7,900,000 | +88.8% | 5,000,000 | 0.0% | 0.11% | +43.0% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $7,190,000 | +25.8% | 1,250,396 | 0.0% | 0.10% | -4.6% | |
| TORC | RESTORBIO INC | $7,197,000 | -83.1% | 4,830,387 | 0.0% | 0.10% | -87.3% | |
| SELB | SELECTA BIOSCIENCES INC | $6,852,000 | +36.0% | 2,879,064 | 0.0% | 0.10% | +2.1% | |
| PFNX | New | PFENEX INC | $6,751,000 | – | 614,868 | +100.0% | 0.10% | – |
| New | APTOSE BIOSCIENCES INC | $6,521,000 | – | 1,150,000 | +100.0% | 0.09% | – | |
| ZGNX | New | ZOGENIX INCcall | $6,516,000 | – | 125,000 | +100.0% | 0.09% | – |
| IONS | New | IONIS PHARMACEUTICALS INC | $6,458,000 | – | 106,900 | +100.0% | 0.09% | – |
| HCAT | HEALTH CATALYST INC | $6,232,000 | +9.7% | 179,598 | 0.0% | 0.09% | -17.6% | |
| NABRIVA THERAPEUTICS PLC | $6,131,000 | -34.0% | 4,644,600 | 0.0% | 0.09% | -50.0% | ||
| ANAB | New | ANAPTYSBIO INC | $6,107,000 | – | 375,800 | +100.0% | 0.09% | – |
| MIST | New | MILESTONE PHARMACEUTICALS IN | $5,831,000 | – | 364,206 | +100.0% | 0.08% | – |
| XLRN | New | ACCELERON PHARMA INC | $5,700,000 | – | 107,500 | +100.0% | 0.08% | – |
| ATRC | New | ATRICURE INC | $5,482,000 | – | 168,621 | +100.0% | 0.08% | – |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $5,351,000 | +59.6% | 249,600 | +12.9% | 0.08% | +18.8% |
| PSNL | PERSONALIS INC | $5,274,000 | -25.7% | 483,842 | 0.0% | 0.08% | -44.4% | |
| SYBX | SYNLOGIC INC | $5,237,000 | +12.6% | 2,029,996 | 0.0% | 0.08% | -14.8% | |
| INCY | New | INCYTE CORP | $5,196,000 | – | 59,500 | +100.0% | 0.07% | – |
| ARNA | ARENA PHARMACEUTICALS INC | $4,996,000 | -0.8% | 110,000 | 0.0% | 0.07% | -26.0% | |
| ACAD | ACADIA PHARMACEUTICALS INC | $4,113,000 | +18.9% | 96,143 | 0.0% | 0.06% | -10.6% | |
| NTLA | Sell | INTELLIA THERAPEUTICS INC | $3,845,000 | -12.1% | 262,100 | -20.0% | 0.06% | -33.7% |
| DERM | New | DERMIRA INCcall | $3,790,000 | – | 250,000 | +100.0% | 0.05% | – |
| AZN | New | ASTRAZENECA PLCsponsored adr | $3,470,000 | – | 69,600 | +100.0% | 0.05% | – |
| SNY | New | SANOFIsponsored adr | $3,434,000 | – | 68,400 | +100.0% | 0.05% | – |
| ARPO | AERPIO PHARMACEUTICALS INC | $3,238,000 | -8.3% | 5,193,946 | 0.0% | 0.05% | -31.3% | |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $2,934,000 | – | 34,700 | +100.0% | 0.04% | – |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $2,859,000 | +536.7% | 160,541 | +314.5% | 0.04% | +355.6% |
| ICPT | Sell | INTERCEPT PHARMACEUTICALS IN | $2,825,000 | +32.2% | 22,800 | -29.2% | 0.04% | -2.4% |
| FLXN | New | FLEXION THERAPEUTICS INC | $2,753,000 | – | 133,000 | +100.0% | 0.04% | – |
| CRIS | Buy | CURIS INC | $2,309,000 | -17.0% | 1,358,363 | +9.4% | 0.03% | -37.7% |
| MYOK | Sell | MYOKARDIA INC | $2,033,000 | -95.0% | 27,900 | -96.4% | 0.03% | -96.3% |
| SNDX | SYNDAX PHARMACEUTICALS INC | $1,861,000 | +17.5% | 212,000 | 0.0% | 0.03% | -10.0% | |
| NVUS | NOVUS THERAPEUTICS INC | $1,846,000 | -6.5% | 3,183,314 | 0.0% | 0.03% | -29.7% | |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $1,748,000 | – | 71,300 | +100.0% | 0.02% | – |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $1,621,000 | -20.5% | 1,350,655 | 0.0% | 0.02% | -41.0% | |
| IMGN | New | IMMUNOGEN INC | $1,464,000 | – | 286,800 | +100.0% | 0.02% | – |
| INSM | Sell | INSMED INC | $1,409,000 | -85.8% | 59,000 | -89.5% | 0.02% | -89.4% |
| OTIC | New | OTONOMY INC | $1,343,000 | – | 350,700 | +100.0% | 0.02% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $1,348,000 | – | 191,209 | +100.0% | 0.02% | – |
| SPRO | Sell | SPERO THERAPEUTICS INC | $1,266,000 | -15.1% | 131,653 | -6.4% | 0.02% | -35.7% |
| RGNX | New | REGENXBIO INC | $1,098,000 | – | 26,800 | +100.0% | 0.02% | – |
| STRO | New | SUTRO BIOPHARMA INC | $1,153,000 | – | 104,800 | +100.0% | 0.02% | – |
| MBIO | New | MUSTANG BIO INC | $1,027,000 | – | 251,685 | +100.0% | 0.02% | – |
| BMYRT | New | BRISTOL MYERS SQUIBB COright 99/99/9999 | $1,054,000 | – | 350,000 | +100.0% | 0.02% | – |
| RUBY | RUBIUS THERAPEUTICS INCput | $950,000 | +21.0% | 100,000 | 0.0% | 0.01% | -6.7% | |
| ZFGN | New | ZAFGEN INC | $911,000 | – | 821,000 | +100.0% | 0.01% | – |
| APTX | New | APTINYX INC | $489,000 | – | 143,000 | +100.0% | 0.01% | – |
| BLRX | BIOLINERX LTDsponsored ads | $156,000 | -14.8% | 69,240 | 0.0% | 0.00% | -33.3% | |
| MDGS | MEDIGUS LTDsponsored ads | $26,000 | 0.0% | 15,000 | 0.0% | 0.00% | – | |
| CVM | Exit | CEL SCI CORPput | $0 | – | -125,000 | -100.0% | -0.02% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INCcall | $0 | – | -150,000 | -100.0% | -0.03% | – |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -662,600 | -100.0% | -0.06% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -50,000 | -100.0% | -0.07% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS I | $0 | – | -835,842 | -100.0% | -0.10% | – |
| ALDR | Exit | ALDER BIOPHARMACEUTICALS INCput | $0 | – | -350,000 | -100.0% | -0.12% | – |
| EHTH | Exit | EHEALTH INCcall | $0 | – | -100,000 | -100.0% | -0.13% | – |
| PBYI | Exit | PUMA BIOTECHNOLOGY INC | $0 | – | -636,600 | -100.0% | -0.13% | – |
| SIBN | Exit | SI BONE INC | $0 | – | -422,000 | -100.0% | -0.14% | – |
| RARX | Exit | RA PHARMACEUTICALS INC | $0 | – | -376,894 | -100.0% | -0.17% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCput | $0 | – | -150,000 | -100.0% | -0.23% | – |
| TAK | Exit | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $0 | – | -750,000 | -100.0% | -0.24% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -623,859 | -100.0% | -0.28% | – |
| IBB | Exit | ISHARES TRput | $0 | – | -200,000 | -100.0% | -0.38% | – |
| ONCE | Exit | SPARK THERAPEUTICS INC | $0 | – | -244,900 | -100.0% | -0.45% | – |
| RARE | Exit | ULTRAGENYX PHARMACEUTICAL IN | $0 | – | -834,313 | -100.0% | -0.68% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -1,588,069 | -100.0% | -0.85% | – |
| PRNB | Exit | PRINCIPIA BIOPHARMA INC | $0 | – | -1,605,713 | -100.0% | -0.86% | – |
| WMGI | Exit | WRIGHT MED GROUP N V | $0 | – | -3,837,250 | -100.0% | -1.50% | – |
| AVDR | Exit | AVEDRO INC | $0 | – | -4,240,128 | -100.0% | -1.83% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
| 3 | 2024-03-27 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.